GLP-1 drugs function by delaying gastric emptying, meaning heavy, dense fats and proteins can sit in the stomach for hours, triggering nausea and discomfort
Although its anti-inflammatory properties may contribute to OSAS improvement, the complexity of immune regulation raises the possibility of unforeseen immune-related effects
More targeted research examining bone turnover markers and bone mineral density (BMD) measurements has shown inconsistent results
patients on such treatments should consult their specialist
Some human topical GHK-Cu research has used study periods around 12 weeks
In 1949, Australian physician John Cade used high doses of the mineral to treat mania. By the 1970s, pharmaceutical lithium had been approved by the FDA for acute mania and recurrent mania, and it became the standard treatment for manic depression